Trial intelligence / Profile preview

Bioavailability of Ibupirac vs Alivium in Healthy Volunteers

NCT01466517Phase 4Completed

Sponsor
Pfizer
Start
Nov 2011
Primary completion
Nov 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of Ibupirac in pain, fever, inflammation, sponsored by Pfizer. Started Nov 2011; status: completed.

02

Drugs

Ibupirac
03

Conditions

painfeverinflammation

Beyond the preview

Go deeper on NCT01466517.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01466517.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call